Contract Lifecycle Management Capability Owner

California Twp, Michigan, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Genomic Technology, Biotechnology, HealthcareIndustries

Requirements

Candidates must have a Certified Product Owner (CSPO or equivalent) certification and at least 5 years of experience as a Product Owner or in a similar role, focusing on enterprise software solutions. A minimum of 3 years of hands-on experience with Conga Apttus CLM and CPQ, including configuration, implementation, and optimization, is required. Proven success in driving user adoption for complex enterprise software across multiple departments, a strong understanding of the contract lifecycle, excellent analytical and problem-solving skills, and exceptional communication, presentation, and interpersonal skills are also necessary. Experience in a fast-paced environment and a Bachelor's degree in Business, Computer Science, or a related field are required.

Responsibilities

The Contract Lifecycle Management Capability Owner will define and evangelize the CLM vision and roadmap, aligning it with business objectives to maximize revenue generation and operational efficiency. They will manage and prioritize the CLM product backlog, translating business requirements into user stories and acceptance criteria, and leverage in-depth knowledge of Conga CLM to optimize its configuration, functionality, and integration. Responsibilities include collaborating with sales, deal desk, legal, finance, and IT teams, developing and executing strategies to drive user adoption, monitoring and measuring the success of CLM initiatives, and staying abreast of industry trends and best practices in CLM and CPQ. Additionally, they will act as a servant leader within an Agile development environment, fostering collaboration and continuous improvement.

Skills

Contract Lifecycle Management (CLM)

Conga CLM

Conga CPQ

Product Backlog Management

User Adoption

Revenue Generation

Operational Efficiency

Stakeholder Collaboration

Sales Processes

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free